Use the lowest effective dose (5001,000 mg per dose) and avoid exceeding 3,0004,000 mg daily
This approach stays intentionally low, aiming for a personalized balance between results and tolerability
Some people may notice a slight decrease in hunger or smaller portion sizes, but significant weight changes are not typical at this early stage
In this pursuit, the synergy between advanced generative AI, some of the world's best medicinal chemists, and rapid testing for safety and other properties is essential to getting to what we hope will be the world's best molecule
News-Medical+3EurekAlert!+3ASMBS+3 To put numbers on it: Surgical patients lost ~58 lbs in two years ( 24% of total body weight, or TBW) GLP-1 patients lost only ~12 lbs ( 4.7% TBW) over the same period EurekAlert!+2News-Medical+2 Even among GLP-1 users who continued therapy for a full year, weight loss averaged only ~7% TBWstill far less than surgical outcomes EurekAlert!+2ASMBS+2 Another rigorous analysis published in JAMA Surgery compared weight loss surgery and GLP-1 receptor agonists over two years
Beyond liver health, these findings contribute to a growing body of evidence that GLP-1based drugs may have benefits well beyond weight loss and diabetes management